344 related articles for article (PubMed ID: 31283429)
1. Gene-Based Dose Optimization in Children.
Ramsey LB; Brown JT; Vear SI; Bishop JR; Van Driest SL
Annu Rev Pharmacol Toxicol; 2020 Jan; 60():311-331. PubMed ID: 31283429
[TBL] [Abstract][Full Text] [Related]
2. Progress and Challenges in Pharmacogenomics.
Van Driest SL; Cascorbi I
Clin Pharmacol Ther; 2021 Sep; 110(3):529-532. PubMed ID: 34412159
[No Abstract] [Full Text] [Related]
3. Pharmacogenomics for Drug Dosing in Children: Current Use, Knowledge, and Gaps.
Hoshitsuki K; Fernandez CA; Yang JJ
J Clin Pharmacol; 2021 Jun; 61 Suppl 1(Suppl 1):S188-S192. PubMed ID: 34185912
[TBL] [Abstract][Full Text] [Related]
4. Progressing the utilisation of pharmacogenetics and pharmacogenomics into clinical care.
Trent RJ; Cheong PL; Chua EW; Kennedy MA
Pathology; 2013 Jun; 45(4):357-70. PubMed ID: 23594690
[TBL] [Abstract][Full Text] [Related]
5. Pharmacogenetics, pharmacogenomics, and individualized medicine.
Ma Q; Lu AY
Pharmacol Rev; 2011 Jun; 63(2):437-59. PubMed ID: 21436344
[TBL] [Abstract][Full Text] [Related]
6. Pharmacogenomics and individualized medicine: translating science into practice.
Crews KR; Hicks JK; Pui CH; Relling MV; Evans WE
Clin Pharmacol Ther; 2012 Oct; 92(4):467-75. PubMed ID: 22948889
[TBL] [Abstract][Full Text] [Related]
7. Pharmacogenomics--how close/far are we to practising individualized medicine for children?
Sing CW; Cheung CL; Wong IC
Br J Clin Pharmacol; 2015 Mar; 79(3):419-28. PubMed ID: 25855823
[TBL] [Abstract][Full Text] [Related]
8. Personalized Medicine in the Paediatric Population: The Balance Between Pharmacogenetic Progress and Bioethics.
Schiavone S; Neri M; Pomara C; Riezzo I; Trabace L; Turillazzi E
Curr Pharm Biotechnol; 2017; 18(3):253-262. PubMed ID: 28176639
[TBL] [Abstract][Full Text] [Related]
9. (Mis)treating the pharmacogenetic incidentalome.
Kohane IS
Nat Rev Drug Discov; 2012 Feb; 11(2):89-90. PubMed ID: 22293554
[TBL] [Abstract][Full Text] [Related]
10. Commentary: A Myriad Aberrations on Information of Ontogeny of Drug Metabolizing Enzymes in the Pediatric Population: An Obstacle for Personalizing Drug Therapy in the Pediatric Population.
Uppugunduri CR; Ansari M
Drug Metab Lett; 2016; 10(2):72-4. PubMed ID: 26908134
[TBL] [Abstract][Full Text] [Related]
11. Pharmacogenomics in Critical Care.
Cheek D; Howington L
AACN Adv Crit Care; 2018; 29(1):36-42. PubMed ID: 29496712
[TBL] [Abstract][Full Text] [Related]
12. Improving Therapeutic Odyssey: Preemptive Pharmacogenomics Utility in Patient Care.
Lazaridis KN
Clin Pharmacol Ther; 2017 Jan; 101(1):39-41. PubMed ID: 27804107
[TBL] [Abstract][Full Text] [Related]
13. Pharmacogenomics: Prescribing Precisely.
Wake DT; Ilbawi N; Dunnenberger HM; Hulick PJ
Med Clin North Am; 2019 Nov; 103(6):977-990. PubMed ID: 31582008
[TBL] [Abstract][Full Text] [Related]
14. NMR-based pharmacometabonomics: A new paradigm for personalised or precision medicine.
Everett JR
Prog Nucl Magn Reson Spectrosc; 2017 Nov; 102-103():1-14. PubMed ID: 29157489
[TBL] [Abstract][Full Text] [Related]
15. Metabolomics in pharmacology - a delve into the novel field of pharmacometabolomics.
Mussap M; Loddo C; Fanni C; Fanos V
Expert Rev Clin Pharmacol; 2020 Feb; 13(2):115-134. PubMed ID: 31958027
[No Abstract] [Full Text] [Related]
16. Perspectives from the Society for Pediatric Research: pharmacogenetics for pediatricians.
Tang Girdwood SC; Rossow KM; Van Driest SL; Ramsey LB
Pediatr Res; 2022 Feb; 91(3):529-538. PubMed ID: 33824446
[TBL] [Abstract][Full Text] [Related]
17. PACE Forward-Making Pharmacogenomics Testing Available for Real-Life Clinical Utility.
Lazaridis KN
Clin Pharmacol Ther; 2019 Jan; 105(1):42-44. PubMed ID: 30520030
[TBL] [Abstract][Full Text] [Related]
18. Pharmacogenetics: has the time come for pharmacists to embrace and implement the science?
Beier MT; Panchapagesan M; Carman LE
Consult Pharm; 2013 Nov; 28(11):696-711. PubMed ID: 24217190
[TBL] [Abstract][Full Text] [Related]
19. Unveiling the guidance heterogeneity for genome-informed drug treatment interventions among regulatory bodies and research consortia.
Koutsilieri S; Tzioufa F; Sismanoglou DC; Patrinos GP
Pharmacol Res; 2020 Mar; 153():104590. PubMed ID: 31830522
[TBL] [Abstract][Full Text] [Related]
20. Precision therapeutics in the NICU: why are we missing the mark?
Lewis T
J Perinatol; 2018 May; 38(5):444-446. PubMed ID: 29379159
[No Abstract] [Full Text] [Related]
[Next] [New Search]